504 related articles for article (PubMed ID: 2941257)
1. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro studies with 4-quinolone antimicrobials.
Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
[TBL] [Abstract][Full Text] [Related]
3. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
Ridgway GL; O'Hare MD; Felmingham D; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(4):259-62. PubMed ID: 2941258
[TBL] [Abstract][Full Text] [Related]
4. [Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
Habiyaremye I; Verbist L; Vandepitte J
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):800-4. PubMed ID: 3116489
[TBL] [Abstract][Full Text] [Related]
5. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
Smith JT
Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
[TBL] [Abstract][Full Text] [Related]
6. The comparative activity of twelve 4-quinolone antimicrobials against gram-positive and gram-negative anaerobes.
Robbins MJ; O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(7):431-4. PubMed ID: 3836865
[TBL] [Abstract][Full Text] [Related]
7. The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms.
Vanhoof R; Hubrechts JM; Roebben E; Nyssen HJ; Nulens E; Leger J; De Schepper N
Infection; 1986; 14(6):294-8. PubMed ID: 3546145
[TBL] [Abstract][Full Text] [Related]
8. [Comparative in vitro effect of 7 quinolones on Ureaplasma urealyticum].
Cantet P; Renaudin H; Quentin C; Bebear C
Pathol Biol (Paris); 1983 Jun; 31(6):501-3. PubMed ID: 6224125
[TBL] [Abstract][Full Text] [Related]
9. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
Renaudin H; Quentin C; de Barbeyrac B; Bebear C
Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of newer quinolones against aerobic bacteria.
Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
[TBL] [Abstract][Full Text] [Related]
11. The comparative activity of twelve 4-quinolone antimicrobials and sulphadiazine against Neisseria meningitidis.
Felmingham D; Wall RA
Drugs Exp Clin Res; 1985; 11(7):427-9. PubMed ID: 3939218
[TBL] [Abstract][Full Text] [Related]
12. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
King A; Phillips I
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the in vitro activity of 6 quinolones on Pseudomonas sp].
Lesage D; Delisle-Mizon F; Vergez P; Daguet GL
Pathol Biol (Paris); 1985 May; 33(5):412-5. PubMed ID: 3162141
[TBL] [Abstract][Full Text] [Related]
14. [Compared antibacterial activity of a new fluoroquinolone, sparfloxacin (AT 4140, RP 64206) and four other fluoroquinolones against 332 strains of enteropathogen bacteria].
Le Noc P; Croizé J; Le Noc D
Pathol Biol (Paris); 1993 Apr; 41(4):294-301. PubMed ID: 8233625
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
[TBL] [Abstract][Full Text] [Related]
16. [In vitro activity of seven gyrase inhibitors of a group of heterocyclic carbonic acids against nonfermenting gram negative rods (nonfermenters)].
Grimm H
Arzneimittelforschung; 1985; 35(3):570-2. PubMed ID: 2986655
[TBL] [Abstract][Full Text] [Related]
17. [In vitro comparative activity of norfloxacin in the comparison of pathogenic bacteria of the urinary tract].
Carlone NA; Cuffini AM; Tullio V; Savoia D; Cavallo GP
G Batteriol Virol Immunol; 1986; 79(1-6):85-97. PubMed ID: 3479370
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin.
Van der Auwera P
Infection; 1986; 14(3):142-4. PubMed ID: 2942489
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
Arpi M; Gahrn-Hansen B; Søgaard P; Bentzon MW
Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
Delmee M; Avesani V
Antimicrob Agents Chemother; 1986 Feb; 29(2):374-5. PubMed ID: 2940968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
